DocDollars

Ocular Therapeutix, Inc.

MA · United States · Reporting entity ID 100000076361

Total reported 2019–2025
$77.1M
#122 of 2,960 reporting companies — 0.1% of all reported industry payments
$8.58M in general payments across 18,305 records, plus $68.5M in research funding across 5,595 records.

How it breaks down

General payments $8,578,946
Research funding $68,481,397

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Ocular Therapeutix, Inc. reported $77.1M to US doctors and teaching hospitals from 2019 to 2025, ranking #122 of 2,960 reporting companies. 89% of that was research funding and 11% general payments such as consulting, speaking, food and travel. 18,305 general payment records and 5,595 research records were filed.

Common questions about Ocular Therapeutix, Inc.

How much has Ocular Therapeutix, Inc. paid US doctors?

Ocular Therapeutix, Inc. reported $77,060,344 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $8,578,946 in general payments, $68,481,397 in research funding.

How does Ocular Therapeutix, Inc. rank among drug and device companies?

It ranks #122 of 2,960 reporting entities by total reported value, about 0.1% of all industry payments in the dataset.

Does a payment from Ocular Therapeutix, Inc. mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.